SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 

BASF nutrition and health jumps 7% to crack €2bn in 2013

By Shane Starling , 25-Feb-2014
Last updated on 25-Feb-2014 at 18:08 GMT2014-02-25T18:08:07Z

BASF nutrition and health jumps 7% to crack €2bn in 2013

‘Nutrition and Health’ was the best performing section within BASF’s ‘Performance Products’ division in 2013, posting a 7% gain on 2012 to push through €2bn in sales for the year.

The other sections of the €15.5bn division – 'Dispersions and Pigements’; ‘Care Chemicals’; ‘Paper Chemicals’ and ‘Performance Chemicals’ – all saw sales diminish compared to 2012.

BASF said its Nutrition and Health division had been boosted by the early 2013 purchase of Norwegian omega-3 giant, Pronova BioPharma, for about €650m. But the VMS space remained challenging.

“…sales to third parties rose by €129 million to €2,088 million in 2013,” the agriculture, ingredients and chemicals giant said.

This considerable growth is attributable to the integration of the acquired Pronova BioPharma ASA business, a leading producer of omega-3 fatty acids. The sales increase was weakened by negative currency effects as well as by lower sales prices mainly resulting from sustained competitive pressure in the vitamins business (volumes 2%, prices –2%, portfolio 10%, currencies –3%).”

“With demand largely stable, we were able to raise our sales volumes in almost all business areas and regions. We posted the largest volumes growth in the pharmaceutical and flavor and fragrance business areas.”

But profits were “considerably” below 2012 levels (not given in detail).

“This was largely because of rising margin pressure and negative currency effects. Fixed costs were higher than the previous year’s level, owing to increased research spending and higher production and selling expenses. Special charges arose from the integration of Pronova BioPharma and measures to increase our competitiveness.”

For the whole group, sales grew 3% to €74bn in the year, with EBIT profits gaining €543m to €7.2bn.

For the final quarter, sales stayed steady at about €18bn with EBIT of €1.6bn.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars